T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.76B |
| 2 |
Eli Lilly
LLY
|
+$1.4B |
| 3 |
Bank of America
BAC
|
+$1.3B |
| 4 |
Tesla
TSLA
|
+$1.19B |
| 5 |
Wells Fargo
WFC
|
+$784M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$6.47B |
| 2 |
Amazon
AMZN
|
+$3.71B |
| 3 |
Yum! Brands
YUM
|
+$2.84B |
| 4 |
Salesforce
CRM
|
+$2.77B |
| 5 |
Fortive
FTV
|
+$2.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.06% |
| 2 | Healthcare | 18.72% |
| 3 | Consumer Discretionary | 14.62% |
| 4 | Financials | 10.36% |
| 5 | Communication Services | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMGO
801
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
| $28.4M | ﹤0.01% |
1,885,112
-35,198
| -2% | -$571K |
|
802
Grab
GRAB
$15.1B
| $28.3M | ﹤0.01% |
10,744,634
-4,963,900
| -32% | -$15M |
|
803
APA Corp
APA
$14B
| $28.3M | ﹤0.01% |
826,330
-3,453,837
| -81% | -$123M |
|
804
Ryman Hospitality Properties
RHP
$7.87B
| $28.2M | ﹤0.01% |
383,272
-38,500
| -9% | -$3.22M |
|
805
W.W. Grainger
GWW
$62.2B
| $28.2M | ﹤0.01% |
57,548
+2,237
| +4% | +$1.18M |
|
806
D.R. Horton
DHI
$41.9B
| $28.1M | ﹤0.01% |
416,965
+399
| +0.1% | +$29.4K |
|
807
Bio-Rad Laboratories Class A
BIO
$9.66B
| $28.1M | ﹤0.01% |
67,278
+339
| +0.5% | +$169K |
|
808
Edison International
EIX
$27.2B
| $28M | ﹤0.01% |
494,603
+977
| +0.2% | +$64.7K |
|
|
PRFT
809
DELISTED
Perficient Inc
PRFT
| $28M | ﹤0.01% |
430,179
+4,959
| +1% | +$414K |
|
|
AEPPZ
810
DELISTED
American Electric Power Company, Inc. Corporate Units
AEPPZ
| – | – |
-585,438
| Closed | -$32M |
|
811
Axcelis
ACLS
$4.42B
| $27.9M | ﹤0.01% |
460,096
+3,512
| +0.8% | +$227K |
|
812
FormFactor
FORM
$10.3B
| $27.8M | ﹤0.01% |
1,108,569
-12,990
| -1% | -$422K |
|
813
SEACOR Marine Holdings
SMHI
$262M
| $27.8M | ﹤0.01% |
4,937,974
| – | – |
|
814
IDEAYA Biosciences
IDYA
$3.53B
| $27.7M | ﹤0.01% |
1,858,877
-27,375
| -1% | -$356K |
|
815
Albany International
AIN
$1.82B
| $27.5M | ﹤0.01% |
349,026
-78,823
| -18% | -$6.78M |
|
|
SGI
816
Somnigroup International
SGI
$14B
| $27.4M | ﹤0.01% |
1,136,687
-139,426
| -11% | -$3.61M |
|
817
Genuine Parts
GPC
$18.7B
| $27.4M | ﹤0.01% |
183,715
-471
| -0.3% | -$71.1K |
|
818
Tenable Holdings
TENB
$4.41B
| $27.4M | ﹤0.01% |
787,695
+150,408
| +24% | +$6.31M |
|
819
The Mosaic Company
MOS
$6.92B
| $27.4M | ﹤0.01% |
566,615
+24,143
| +4% | +$1.25M |
|
820
Red Rock Resorts
RRR
$3.67B
| $27.2M | ﹤0.01% |
794,880
-698,188
| -47% | -$26.5M |
|
821
Skyworks Solutions
SWKS
$10.5B
| $27.2M | ﹤0.01% |
318,961
-64,466
| -17% | -$6.59M |
|
822
H.B. Fuller
FUL
$3.24B
| $27.1M | ﹤0.01% |
451,387
+32,539
| +8% | +$2.07M |
|
823
Evolent Health
EVH
$527M
| $27.1M | ﹤0.01% |
753,086
+715,327
| +1,894% | +$25.2M |
|
824
Herc Holdings
HRI
$5.64B
| $26.9M | ﹤0.01% |
259,359
-278,461
| -52% | -$31M |
|
825
Cencora
COR
$59.2B
| $26.8M | ﹤0.01% |
198,198
+2,311
| +1% | +$332K |
|
Similar funds
T. Rowe Price Associates's Q3 2022 Portfolio in Review
As of Q3 2022, T. Rowe Price Associates held 3,114 positions worth $610B, down 23% from $791B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
T. Rowe Price Associates withdrew a net $168B in Q3 2022, closing 171 positions and reducing 1,248 holdings. Its most notable exit was Alcon, an estimated $1.51B position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, T. Rowe Price Associates opened a new position in Corebridge Financial worth $194M.
- T. Rowe Price Associates's largest Q3 2022 buy was Corebridge Financial: 9,831,688 shares worth $194M.
- T. Rowe Price Associates added most to ExxonMobil in Q3 2022, an estimated $1.76B increase.
- T. Rowe Price Associates's biggest Q3 2022 reduction was Microsoft, cutting an estimated $6.47B.
- T. Rowe Price Associates fully exited Alcon in Q3 2022, selling an estimated $1.51B.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $610B portfolio in Q3 2022.
- T. Rowe Price Associates opened 154 new positions and closed 171 in Q3 2022.
- T. Rowe Price Associates's portfolio value fell 23% quarter-over-quarter to $610B.
Based on T. Rowe Price Associates's 13F filing for Q3 2022, filed 14 Nov 2022.